Literature DB >> 35002553

Ontogeny of Pediatric Pharmacogenetics: Celebrating the Past and Vision for the Future.

J Steven Leeder1.   

Abstract

Entities:  

Keywords:  Sumner Yaffe; Yaffe Award; adolescents; children; clinical pharmacology; pediatric; pharmacogenetics

Year:  2021        PMID： 35002553      PMCID： PMC8717621          DOI： 10.5863/1551-6776-27.1.4

Source DB:  PubMed          Journal:  J Pediatr Pharmacol Ther        ISSN： 1551-6776


× No keyword cloud information.
  27 in total

1.  Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing.

Authors:  M V Relling; E E Gardner; W J Sandborn; K Schmiegelow; C-H Pui; S W Yee; C M Stein; M Carrillo; W E Evans; T E Klein
Journal:  Clin Pharmacol Ther       Date:  2011-01-26       Impact factor: 6.875

Review 2.  Developmental pharmacology of tramadol during infancy: ontogeny, pharmacogenetics and elimination clearance.

Authors:  Karel Allegaert; Alain Rochette; Francis Veyckemans
Journal:  Paediatr Anaesth       Date:  2010-08-17       Impact factor: 2.556

3.  Expression of CYP2D6 in developing human liver.

Authors:  J M Treluyer; E Jacqz-Aigrain; F Alvarez; T Cresteil
Journal:  Eur J Biochem       Date:  1991-12-05

Review 4.  Pharmacogenetics.

Authors:  S N Cohen; W W Weber
Journal:  Pediatr Clin North Am       Date:  1972-02       Impact factor: 3.278

5.  Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update.

Authors:  Mary V Relling; Matthias Schwab; Michelle Whirl-Carrillo; Guilherme Suarez-Kurtz; Ching-Hon Pui; Charles M Stein; Ann M Moyer; William E Evans; Teri E Klein; Federico Guillermo Antillon-Klussmann; Kelly E Caudle; Motohiro Kato; Allen E J Yeoh; Kjeld Schmiegelow; Jun J Yang
Journal:  Clin Pharmacol Ther       Date:  2019-01-20       Impact factor: 6.875

6.  Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity.

Authors:  R M Weinshilboum; S L Sladek
Journal:  Am J Hum Genet       Date:  1980-09       Impact factor: 11.025

7.  Dextromethorphan and caffeine as probes for simultaneous determination of debrisoquin-oxidation and N-acetylation phenotypes in children.

Authors:  W E Evans; M V Relling; W P Petros; W H Meyer; J Mirro; W R Crom
Journal:  Clin Pharmacol Ther       Date:  1989-05       Impact factor: 6.875

8.  Predisposition to phenytoin hepatotoxicity assessed in vitro.

Authors:  S P Spielberg; G B Gordon; D A Blake; D A Goldstein; H F Herlong
Journal:  N Engl J Med       Date:  1981-09-24       Impact factor: 91.245

9.  Thiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations.

Authors:  L Lennard; J A Van Loon; J S Lilleyman; R M Weinshilboum
Journal:  Clin Pharmacol Ther       Date:  1987-01       Impact factor: 6.875

10.  A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferase.

Authors:  E Y Krynetski; J D Schuetz; A J Galpin; C H Pui; M V Relling; W E Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.